Sign in

CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453728228
Phone
510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-03-14 Haurwitz Rachel E. President and CEO Purchase +20,000 $1.02 $20K 3,369,395
2025-01-29 Ryali Sriram Chief Financial Officer Purchase +17,360 $1.42 $25K 17,360
2022-01-11 Fischesser Ryan VP of Finance and Controller Purchase +569 $2.69 $2K 102,264
2022-01-11 Fischesser Ryan VP of Finance and Controller Purchase +6,818 $4.11 $28K 109,082
2021-12-20 Fischesser Ryan VP of Finance and Controller Purchase +1,136 $2.69 $3K 101,695
2021-12-07 MCCLUNG BARBARA G Chief Legal Officer Purchase +12 $2.69 $32 342,856
2021-12-07 MCCLUNG BARBARA G Chief Legal Officer Purchase +6,115 $2.69 $16K 348,971
2021-10-20 MCCLUNG BARBARA G Chief Legal Officer Purchase +9,176 $2.69 $25K 342,801
2021-10-20 MCCLUNG BARBARA G Chief Legal Officer Purchase +43 $2.69 $116 342,844
2021-10-12 Kanner Steven Chief Scientific Officer Purchase +99,548 $1.81 $180K 199,719
2021-10-12 Kanner Steven Chief Scientific Officer Purchase +698 $1.81 $1K 200,417
2021-10-12 Kanner Steven Chief Scientific Officer Purchase +14,614 $2.69 $39K 215,031
2021-10-11 Fischesser Ryan VP of Finance and Controller Purchase +1,746 $2.69 $5K 100,559

Page 1 of 1 · 13 trades